Sino Biopharmaceutical Azioni (OTC: SBMFF)

Ultime notizie per Sino Biopharmaceutical (OTC:SBMFF) Azioni

Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2023, 37.8% of the firm's total revenue comes from five innovative drugs and five biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 33.6% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.

SINO BIOPHARM ORD by Sino Biopharmaceutical Ltd.

Sino Biopharmaceutical Ltd

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical Limited announced promising phase III results for their drug Culmer...

Sino Biopharmaceutical's Breakthrough in Breast Cancer Treatment

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical Limited announced promising Phase III clinical trial results for An...

Sino Biopharmaceutical's Promising Cancer Drug Results

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has announced positive Phase III study results for Anlotinib Hydroc...

Sino Biopharm Unveils Promising Cancer Drug Results

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has announced the approval of its Rivastigmine Transdermal Patch, a...

Sino Biopharmaceutical Launches Alzheimer's Patch

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has presented positive phase III study results for Culmerciclib in ...

Sino Biopharmaceutical Reveals Promising Cancer Drug Results

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical Limited has announced the purchase of 8 million shares on October 3...

Sino Biopharmaceutical Buys Back Shares

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical announced that its subsidiary Chia Tai Tianqing has bought shares w...

Sino Biopharmaceutical Boosts Employee Incentives

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical has announced the purchase of 6 million shares, at an average price...

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical, through its subsidiary Chia Tai Tianqing, has entered an exclusive...

Sino Biopharmaceutical Signs Key Drug Deal

Sino Biopharmaceutical (HK:1177) has released an update. Sino Biopharmaceutical Limited has announced that its subsidiary, Chia Tai Tianqing Pharma...

Comments

Sino Biopharmaceutical

Notizie

Ultime notizie per Sino Biopharmaceutical (OTC:SBMFF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO